On a standard U-100 insulin syringe, units measure liquid volume, not medication weight. For the standard compounded semaglutide concentration of 2.5 mg/mL:
• 0.25 mg (Starter Dose) = 10 units (0.10 mL)
• 0.50 mg (Step 2 Dose) = 20 units (0.20 mL)
• 1.00 mg (Intermediate Dose) = 40 units (0.40 mL)
• 1.70 mg (Therapeutic Dose) = 68 units (0.68 mL)
• 2.40 mg (Maximum Dose) = 96 units (0.96 mL)
1. The Golden Conversion Formula (MG to Units)
The most frequent source of dosing errors in at-home compounded peptide administration is confusing milligrams (mg) with syringe units. Milligrams describe the physical mass of active semaglutide peptide. Syringe units describe the volume of liquid solution drawn into the barrel.
To calculate your exact units, use this universal clinical formula:
Syringe Units = Volume in mL × 100
2. Complete Semaglutide Units to MG Conversion Table
Locate your prescribed dose and the exact concentration printed on your 503A compounding pharmacy label:
| Prescribed Dose (mg) | Clinical Protocol Stage | Units @ 2.5 mg/mL (Standard) | Units @ 5.0 mg/mL (High Conc.) | Volume in mL |
|---|---|---|---|---|
| 0.25 mg | Weeks 1–4 (Initiation) | 10 Units | 5 Units | 0.10 mL |
| 0.50 mg | Weeks 5–8 (Escalation) | 20 Units | 10 Units | 0.20 mL |
| 1.00 mg | Weeks 9–12 (Efficacy) | 40 Units | 20 Units | 0.40 mL |
| 1.70 mg | Weeks 13–16 (Accelerated) | 68 Units | 34 Units | 0.68 mL |
| 2.40 mg | Weeks 17+ (Max Maintenance) | 96 Units | 48 Units | 0.96 mL |
3. Reading Your U-100 Syringe Correctly
U-100 insulin syringes are calibrated so that 100 units equals 1.0 mL. Depending on your pharmacy supplies, you will typically receive one of three barrel sizes:
- 0.3 mL Syringe (30 Units Max): Best for starter doses (0.25mg / 10 units and 0.5mg / 20 units). Each small tick mark equals 1 unit.
- 0.5 mL Syringe (50 Units Max): Ideal for intermediate doses up to 1.0mg (40 units). Each tick mark equals 1 unit.
- 1.0 mL Syringe (100 Units Max): Required for high doses (1.7mg / 68 units and 2.4mg / 96 units). Ticks are spaced closely; verify the line carefully at eye level.
Common Calculation Pitfalls & How to Prevent Overdosing
Because compounded semaglutide vials are formulated by different 503A pharmacies at varying concentrations, mathematical confusion is the single most frequent cause of patient-reported adverse reactions. The two most common clinical pitfalls include:
Warning: Two Critical Errors to Avoid
- Confusing Milligrams (mg) with Syringe Units: Drawing 25 units on a syringe when prescribed 0.25 mg from a 5 mg/mL vial results in injecting 1.25 mg—a five-fold accidental overdose that will trigger acute vomiting, retching, and severe dehydration.
- Assuming All Vials Have the Same Concentration: When switching from a starter vial (often 2.5 mg/mL) to a maintenance vial (often 5.0 mg/mL), the volume in units required to deliver the same milligram dose is cut in half. Always recalculate your unit draw every time you receive a new vial by inspecting the mg/mL label.
Pharmacokinetic Half-Life & Weekly Dosing Stability
Semaglutide has an elimination half-life of approximately 7 days (168 hours), largely facilitated by albumin binding via its synthetic C18 fatty diacid chain. Because of this sustained half-life, steady-state plasma concentrations are achieved after 4 to 5 weeks of consistent weekly dosing.
Maintaining precise unit measurement week after week prevents erratic plasma concentration peaks and troughs, providing smooth, unfluctuating hunger suppression and minimizing gastrointestinal side effects.